Royal Sense Quarterly Results for Trading Insights
ROYAL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹6 Cr
QMarch 2025
Royal Sense Quarterly Results Key Highlights
- Revenue of ₹62 Cr in March 2025 (+0.0% vs March 2025, +244.4% vs March 2024)
- Net Profit of ₹6 Cr in March 2025 (+0.0% vs March 2025, +200.0% vs March 2024)
- EBITDA of ₹9 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 14.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹12.91 in March 2025 (+0.0% vs March 2025)
Royal Sense Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | QoQ | YoY |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 62 | 18 | - | - |
| Net Profit (₹ Cr) | 0 | 6 | 2 | - | - |
| EBITDA (₹ Cr) | 0 | 9 | 2 | - | - |
| EPS (₹) | 0.00 | 12.91 | 3.24 | - | - |
| Operating Margin (%) | 0.0% | 14.0% | 13.0% | - | - |
Royal Sense Share Price Trend Around Quarterly Results
Visualize Royal Sense's 1-year price movement across quarterly results — ideal for logging trades in Royal Sense share price
chart using Tickjournal. All values in ₹.
Related Pages for Royal Sense
Additional stock information and data for ROYAL
Revenue Trend (₹ Cr)
March 2024
18
March 2025
62
2026
0
Net Profit Trend (₹ Cr)
March 2024
2
March 2025
6
2026
0
Operating Margin Trend (%)
March 2024
13.0%
March 2025
14.0%
2026
0.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Royal Sense quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹429,456.97 Cr | 1812.8 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.4 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6372.0 | 2,860 | 689 | +7.1% | - | 24.1% | 245.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4427.8 | 3,219 | 591 | +11.3% | - | 18.4% | 252.4 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,416.93 Cr | 1314.6 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.2 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1333.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.7 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores